Newsroom

Milton Keynes, U.K., 24 June, 2024 – MSD Animal Health, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), today announced the Veterinary Medicine Directorate (VMD) has approved BRAVECTO® (fluralaner) 150 mg/ml powder and solvent for suspension for injection for dogs. This new injectable fluralaner formulation is approved for the immediate and persistent […]

Read more

With eight weeks to the deadline, a third of cat owners in England are unaware their pet will be required by law to be microchipped MILTON KEYNES, U.K., 11 Apr, 2024 – New research from HomeAgain®, released to mark National Pet Day, Thursday 11 April 2024, reveals 1.5 million UK cat owners have not microchipped […]

Read more

MILTON KEYNES, UK, 27th February 2024 – More than 30% of GB sheep flocks don’t know their barren ewe rate or are reporting a figure greater than 5% after lambing.             This concerning finding comes from an on-line survey of 966 sheep flocks conducted by MSD Animal Health (a division of Merck & Co., Inc., […]

Read more

MILTON KEYNES, U.K., 11th January 2024 – MSD Animal Health UK Limited (a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)) has added an entry-level model to its range of Alligator Pro mobile sheep handling systems. The new Alligator Pro SK (Starter Kit) has been specifically designed to provide the ideal solution […]

Read more

MSD Animal Health UK is proud to be donating over 30 000 microchips, including HomeAgain® microchips, to animal welfare charities the RSPCA, Hearing Dogs, Redwings, Bransby Horse Rescue, and the Donkey Sanctuary, as part of its commitment to improving animal health. The HomeAgain microchip allows dog, cat, and horse owners to update their contact information […]

Read more

MILTON KEYNES, U.K., 7th March 2023 – The latest round of farm equipment and technology grants has made herd monitoring systems such as SenseHub® and Dataflow II from MSD Animal Health UK Limited (a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)) more affordable in England. The option to use SenseHub and […]

Read more

MILTON KEYNES, U.K., Feb. 8, 2023 – MSD Animal Health UK Limited, a subsidiary of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), is pleased to announce that the British Trout Association (BTA) has given Dr Chris Gould, Associate Director – Global Aquaculture Technical Service, Cold Water Biopharma, the Peter Jones Award, which honours individuals […]

Read more

Proprietary Technology Enhances Health and Environmental Monitoring Solutions for Poultry Producers Milton Keynes, UK 25 February 2021 – MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK) today announced the completion of its acquisition of PrognostiX Poultry Limited d/b/a Poultry Sense Ltd. from its founding shareholders. Poultry Sense Ltd. is […]

Read more

Milton Keynes, UK, 9 February 2021 – MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, N.J., USA (NYSE:MRK), today received two prestigious awards from Animal Pharm, the most widely read publication reporting on the animal health industry. Richard DeLuca was recognized with the  2020 Visionary/CEO award and NOBILIS® SALENVAC® ETC was awarded […]

Read more